American Laboratory Products Company, Ltd. (ALPCO), a specialty in vitro diagnostics company, today announced the majority recapitalization of the company by Ampersand Capital Partners. Ampersand’s investment will be used to support ALPCO’s worldwide growth initiatives, including the expansion of the company’s diagnostics test kit offering, broadening the company’s geographic presence, and fueling internal R&D product development and production operations.
ALPCO is a Salem, NH-based in vitro diagnostics company that offers specialty immunoassay products (IVD and RUO) primarily focused on the clinical gastroenterology and diabetes research segments. Founded in 1990 by Richard and Jan Conley as an importer and distributor of immunoassay-based products for the North American life science markets, the company is now a leading global provider of both distributed and proprietary diagnostics products. As part of the transaction, Richard and Jan Conley will remain shareholders in the company, and Sean Conley will continue to lead the business as CEO. ALPCO has also announced the appointment of Larry McCarthy, PhD as Chairman of the company’s Board of Directors.
“We are very excited to partner with Sean and his team to continue to grow the business,” stated Eric Lev, General Partner at Ampersand. “With our operating and investment experience within the laboratory products and diagnostics markets, coupled with an injection of growth capital, we believe that ALPCO is poised to be a market leader in specialty immunoassay products worldwide.”
Sean Conley added: “We have always been committed to offering our customers the solutions they need to both advance the quality of care and enable better medical research. I am confident that this partnership with Ampersand will allow us to grow as an organization and better serve our customers as we invest in our infrastructure and service offering.”
PCX Aerosystems Announces Acquisition of NuSpace
PCX Aerosystems (“PCX”), a market-leading producer of advanced mechanical systems for the aerospace industry, today announced the September 2, 2022 acquisition of NuSpace, Inc. (“NuSpace”) from Cornerstone Capital Holdings and members of the NuSpace leadership team. With engineering and manufacturing roots going back to 1907, NuSpace has evolved from a diversified mechanical systems manufacturer into a leading-edge designer and manufacturer of proprietary propellant and high-pressure tanks for advanced satellite, launch vehicle spacecraft, and missile platforms.
“NuSpace brings a unique capability to design and produce mission critical complex assemblies for the rapidly growing space marketplace which is a fantastic addition to the growing portfolio of flight-critical components and assemblies we supply to the defense aerospace market,” said PCX CEO, Tom Holzthum.
Ian Ballinger, CEO and Chief Technology Officer of NuSpace, said, “Joining the PCX team is a natural next step for NuSpace, bringing the stability and support of being part of a broader portfolio while maintaining the freedom to pursue continued growth with our customers.”
Headquartered in Connecticut, PCX Aerosystems is a leading privately owned supplier of highly engineered, precision, flight critical assemblies for rotorcraft and fixed wing aerospace platforms The company produces rotorhead assemblies and control systems, landing gear assemblies, external fuel tank systems, engine and structural airframe components in addition to composite fabrications and refueling probes. The company also offers integrated special processing services such as heat treating, painting and non-destructive testing. PCX provides direct delivery of components and large assemblies to customers such as Boeing, General Electric Aircraft Engines, Bell, Sikorsky and the U.S. Government. Founded in 1900, PCX owns facilities in CT, CA and MA. PCX Aerostructures, LLC, dba PCX Aerosystems is owned by Greenbriar Equity Group, L.P. To learn more about PCX, visit www.pcxaero.com.
NuSpace is a Long Beach, California based aerospace and defense manufacturer with proprietary design and specialized fabrication capabilities, and flight-critical assembly and quality systems. Their experienced engineering and manufacturing teams excel at the design to specification and manufacture of mission critical propellant and pressure vessel solutions.
Korean cosmetics giant Amorepacific acquires luxury clean beauty brand Tata Harper
Amorepacific today announced that it has entered into a definitive agreement to acquire Tata’s Natural Alchemy, LLC (“Tata Harper” or the “Company”), a pioneer in natural luxury skincare, in a move that further signals the company’s intention to continue its penetration of global markets with a firm focus on consumers in North America. The closing of the acquisition is expected to occur in early 4Q 2022. Tata Harper, the Company’s co-founder, will continue to lead the brand.
Since its creation in 2010, Tata Harper has defined the luxury skincare category by strictly adhering to its core principle of clean beauty in everything from product development to packaging. The brand’s mission of “beauty made without compromise” has enabled Tata Harper to develop and maintain a strong global fan base. The Company uses 100% naturally derived ingredients without any genetically modified organisms (GMOs), toxins, fillers, artificial colors / fragrances, or synthetic chemicals. With a primary focus on the U.S. market, Tata Harper currently sells its products in 25 online stores, including its own direct-to-consumer website, Net-a-Porter, and Cult Beauty, as well as in over 800 brick-and-mortar retailers such as Sephora, Bluemercury, and Neiman Marcus. Tata Harper received a minority investment from Alliance Consumer Growth in 2015.
“Tata Harper is a clean beauty brand instilled with the core values of healthy beauty – values that society and consumers are looking for today. Fueled by Amorepacific’s top-notch R&D and P&L infrastructure, we expect Tata Harper will be able to significantly expand its footprint in the Western and Asian markets,” said Jinpyo Lee, Chief Strategy Officer at Amorepacific Group.
The acquisition of Tata Harper will be highly additive to Amorepacific’s current offering. By diversifying its distribution channels, the Korean cosmetics giant will expand its business to the Americas and Europe, while realigning strategies to further broaden its presence in Asian markets. Amorepacific will continue to promote flagship product categories through intensive marketing activities, while simultaneously boosting product competitiveness through joint research and expanding new categories. Amorepacific will also enhance the profitability of Tata Harper by leveraging its scale and streamlining a variety of internal processes.
Co-founder and co-CEO, Tata Harper, commented, “Henry and I founded the brand on our farm in Vermont in our quest to develop a portfolio of products which will deliver efficacious results and a luxury experience without having to compromise your health. Our approach to formulation, including full control of manufacturing, has allowed us to pioneer the next generation of beauty. I look forward to leveraging Amorepacific’s expertise to drive global growth and continue to serve our consumers, who rely on Tata Harper to deliver the most results from their skincare.”
As a global beauty company, Amorepacific Group continues to post high growth in North America, thanks to the recent diversification of its global businesses. According to the 2Q 2022 earnings release, sales in North America jumped by 66% year-on-year, led by global brands including LANEIGE, Sulwhasoo, and innisfree, among others. The recent strong sales performance is backed by wider sales channels through brand stores and e-commerce, which is in line with current market trends. Furthermore, aggressive marketing of best-sellers for each of the respective brands, as well as successful collaborations with local influencers, powered higher brand awareness. Amorepacific continues to strengthen its presence as an innovative skincare brand, with LANEIGE ranked as the most widely sold Beauty & Personal Care brand, and Sulwhasoo’s First Care Activating Serum EX completely sold out during Amazon Prime Day this year.
UBS Investment Bank and K&L Gates acted as Amorepacific’s financial and legal advisors, respectively. Goldman Sachs & Co. LLC and Arnold & Porter acted as Tata Harper’s financial and legal advisors, respectively.
WebMD Acquires JIM.fr, Expanding Reach to French-Speaking Health Professionals
WebMD Health Corp., an Internet Brands company and a leader in health information services for physicians, other healthcare professionals and consumers, today announced that it has acquired JIM.fr, a leading medical news, information and education platform in France.
The acquisition combines the core competencies of JIM.fr with that of Medscape, WebMD’s flagship global brand for healthcare professionals (HCPs). Medscape and its affiliate network of platforms currently reach over 5 million physicians worldwide with clinical news, health information and continuing medical education. With the addition of JIM.fr, Medscape deepens its commitment to French and French-speaking HCPs.
“Both JIM.fr and Medscape have the trust and engagement of hundreds of thousands of healthcare professionals in France,” said Jeremy Schneider, Group General Manager, WebMD Global. “Medscape’s existing French edition, along with our robust, country-specific content, is integral to our global commitment to French-speaking health professionals. Through this transaction, we can leverage our combined assets to further strengthen Medscape’s offering for French and French-speaking professionals, while delivering innovative solutions to customers.”
As a leading medical news site in France, JIM.fr engages hundreds of thousands of physicians, nurses, pharmacists and other HCPs across more than 25 specialties. In addition to updates on the latest medical news, clinical science, and medical conference coverage, JIM.fr offers a multidisciplinary and interactive continuing education platform for the broad healthcare team.
“Today JIM.fr offers, every day, to more than 350,000 French-speaking healthcare professionals registered on its site, a complete panorama of medical and professional news in all specialties, including general medicine,” said Dr. Gilles Haroche, founder of JIM.fr. “Beyond the scientific and journalistic rigor of its articles, JIM distinguishes itself from other medical media by its often humorous tone and its original analyses of all the major issues that are shaking the medical world. We are very happy to see the quality of our work recognized by Medscape, the global medical news and point of care platform.”
Following closing, JIM.fr will continue to operate as an independent subsidiary of Medscape as the companies look to build on and integrate products, platforms, and services.
The terms of the acquisition are not being disclosed.
About WebMD Health Corp.
WebMD Health Corp., an Internet Brands company, is at the heart of the digital health revolution that is transforming the healthcare experience for consumers, patients, healthcare professionals, employers, health plans and health systems. Through public and private online portals, mobile platforms, and health-focused publications, WebMD delivers leading-edge content and digital services that enable and improve decision-making, support and motivate health actions, streamline and simplify the healthcare journey, and improve patient care.
The WebMD Health Network includes WebMD Health, Medscape, Jobson Healthcare Information, MediQuality, Frontline, Vitals Consumer Services, Aptus Health, Krames, PulsePoint, The Wellness Network, SanovaWorks, MNG Health, MedicineNet, eMedicineHealth, RxList, OnHealth, Medscape Education, and other owned WebMD sites. WebMD®, Medscape®, CME Circle®, Medpulse®, eMedicine®, MedicineNet®, theheart.org® and RxList® are among the trademarks of WebMD Health Corp. or its subsidiaries.
Dr. Gilles Haroche, then an intern at “Hôpitaux de Paris” (Hospital chain, Paris), founded the “Journal International de Médecine” (The JIM) in 1979, which switched to an entirely digital format in 1999. The JIM has always fulfilled the mission expressed in its title International Journal of Medicine.
Thanks to the daily editorial collaboration of dozens of hospital and private practitioners, JIM has set itself the goal of informing its readers in French, in “real time”, of everything important that is being done and written in medicine around the world in the international scientific press, major congresses and professional news. Its rigor and its free and sometimes offbeat tone have made it a success with its readers, and therefore with its advertisers. JIM has always been ranked among the leading digital media sites for HCPs in France.
Singapore based eCommerce solution provider Graas accelerates regional growth with key senior hires
Logistics Startup MOVIN expands its network to 28 cities, adds a new strategic hub in Mumbai
Future™ Secures $5.3M Seed Investment to Pay You to Fight Climate Change.
Interview3 years ago
An Interview with Joel Arun Sursas, Head of Clinical Affairs at Biorithm, Singapore
More3 years ago
6 Promising Up and Coming Fashion Companies
More4 years ago
Factors to Consider When Planning Your Office Design and Layout
Interview2 years ago
An Interview with Russell Jack, Southland-based Yogapreneur and Mindfulness Teacher
Other Internet Tech4 years ago
How to become an IPTV reseller? A beginner’s guide
More4 years ago
IPTV business for beginners
Business Ideas5 years ago
50 Small Business ideas with low investment
More4 years ago
Advantages of Using Ride-hailing Services for Transportation